Market Cap$17.03B
P/E70.62x
PEG Ratio0.73
Div yield0.31%
Beta1.09
RVTY Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)53.33%
Price vs S&P 500 (4W)7.63%
PEG Ratio0.73
VGM Score48.08
P/E Ratio (Annual)70.62x
Indicated Dividend Yield (Annual)0.31%
RVTY Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.22 | $1.41 | +15.93%(+$0.19) | |
| Q1 2026 | $1.01 | $1.06 | +4.47%(+$0.05) | |
| Q4 2025 | $1.58 | $1.70 | +7.80%(+$0.12) | |
| Q3 2025 | $1.14 | $1.18 | +3.63%(+$0.04) | |
| Q2 2025 | $1.14 | $1.18 | +3.36%(+$0.04) |
RVTY Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.75
3.72
3.72
3.72
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | A | B | — | — | — | — | $25.28 |
About Revvity, Inc.
Revvity, formed in 2023 through PerkinElmer's rebranding, is a global life sciences and diagnostics company serving biopharma, academic research, and clinical markets. The company operates two segments: Life Sciences, providing reagents and instruments for research applications, and Diagnostics, delivering immunodiagnostics and newborn and reproductive health solutions. With established operations across North America, Europe, and China, Revvity serves customers worldwide in research and clinical diagnostics.